We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Stabilized Urinary Biogenic Amines Measured in Clinical Chemistry Laboratories

By LabMedica International staff writers
Posted on 23 Feb 2021
Print article
Image: The Dionex CoulArray Coulometric Array Detector (Photo courtesy of Thermo Fisher Scientific).
Image: The Dionex CoulArray Coulometric Array Detector (Photo courtesy of Thermo Fisher Scientific).
Carcinoid tumors are rare neuroendocrine tumors deriving from enterochromaffin cells secreting serotonin. The measurement of urinary 5-hydroxyindoleacetic acid (5-HIAA), the main product of serotonin metabolism, is used for the diagnosis and follow-up for this tumor.

Neuroblastomas are neoplasms that arise from neural crest-derived cell precursors of postganglionic sympathetic neurons and are characterized by excessive production of catecholamines (CATs). 5-HIAA, vanillylmandelic (VMA), homovanillic acid (HVA), catecholamines and metanephrines are produced in excess by catecholamine-producing tumors.

Medical Biochemists at the Lausanne University Hospital (Lausanne, Switzerland) obtained 22 urine spots from enrollees (aged 25 to 65, 50% males) and were aliquoted in 250 µL polypropylene tubes. The pH of urines was immediately measured using pH indicator strips. Each of the 22 urine samples was split into three sub-samples, one of which was supplemented by 5 mL of 6 M HCl per liter of urine (“HCl urine”), the second by 10 grams citrate per liter of urine (“citrate urine”), and the third was unmodified (“native urine”).

All the analytical methods used throughout the study were the routine methods from the laboratory and were fully validated. 5-HIAA, VMA, and HVA were measured in one aliquot by LC-MS/MS using a dilute-and-shoot sample preparation. The CATs were quantified in the third aliquot using the RECIPE catecholamine kit (Munich, Germany) using a 5600A electrochemical CoulArray system coupled to an isocratic HPLC (ESA-Dionex, Sunnyvale, CA, USA). CATs were also quantified by LC-MS/MS.

The scientists reported that that catecholamines degradation was prevented by HCl and citrate and that 5-HIAA was degraded in five out of 22 samples collected with HCl. All biogenic amines were efficiently stabilized by citrate for four weeks at 22 °C, except epinephrine (48 hours at 4 °C, or four weeks at −20 °C). Sodium citrate did not cause quantification or analytical artifacts concerns.

The authors concluded that sodium citrate is a non-hazardous alternative to HCl for patients to send unfrozen urine samples to the laboratory which may safely store the sample for four weeks. The team proposes to replace HCl by sodium citrate for stabilizing urinary 5-HIAA, VMA, HVA, catecholamines and total metanephrines as a safe alternative for clinical chemistry laboratory and patients. The study was published in the March, 2021 issue of the journal Clinica Chimica Acta.

Related Links:
Lausanne University Hospital

Gold Supplier
Nucleic Acid Extractor
COVID-19 Antigen Rapid Test
COVID-19 Antigen RT (NP Swab)
Silver Supplier
SARS-CoV-2 qRT-PCR IVD Reagent Kit
COVID-19 Antigen Test
Instant-view PLUS COVID-19 Antigen Test

Print article
BIOHIT  Healthcare OY



view channel
Image: Quidel Receives Amended FDA Emergency Use Authorization for New AI-Powered Sofia Q Rapid Antigen Test Device (Photo courtesy of Quidel Corporation)

Quidel Receives Amended FDA Emergency Use Authorization for New AI-Powered Sofia Q Rapid Antigen Test Device

Quidel Corporation (San Diego, CA, USA) has received an amended Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) allowing the company to market Sofia Q, its latest addition... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.